M. Beauduin
- Oncology top 5%
- Cancer Treatment and Pharmacology 17
- HER2/EGFR in Cancer Research 7
- Radiation top 5%
- Nuclear Physics and Applications 6
- Cancer Research top 10%
- Breast Cancer Treatment Studies 16
- Hematology top 10%
-
- Radiation Therapy and Dosimetry 5
- Prostate Cancer Treatment and Research 5
-
- Estrogen and related hormone effects 8
-
- Cancer therapeutics and mechanisms 4
- Co-authors
- F. MajoisYves HumbletJ LonguevilleP. WeynantsA. VindevoghelAndré WambersieMartine PiccartMichel Symann
- Cited by
- OncologyRadiationCancer Research
- Journals
- European Journal of Cancer (7 papers)Journal of Clinical Oncology (7 papers)Radiotherapy and Oncology (4 papers)
- Partner nations
- BelgiumFranceUnited States
In The Last Decade
M. Beauduin
67 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 88
- Oncology 662
- Radiation 133
- Cancer Research 224
- Hematology 142
- Pulmonary and Respiratory Medicine 330
Countries citing papers authored by M. Beauduin
This map shows the geographic impact of M. Beauduin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Beauduin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Beauduin more than expected).
Fields of papers citing papers by M. Beauduin
This network shows the impact of papers produced by M. Beauduin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Beauduin. The network helps show where M. Beauduin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M. Beauduin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 29 | |
| 2 | 2004 | 9 | |
| 3 | 2004 | 8 | |
| 4 | 2001 | 12 | |
| 5 | 2001 | 39 | |
| 6 | 2001 | 27 | |
| 7 | 2000 | 8 | |
| 8 | Levamisole adds granulocyte toxicity to 5FU-based chemotherapies in adjuvant treatment of Dukes B-C colorectal cancer. A preliminary report. | 1995 | 1 |
| 9 | 1994 | 5 | |
| 10 | [Can benign and malignant thyroid nodules be differentiated with thallium 201?]. | 1993 | 5 |
| 11 | 1993 | 71 | |
| 12 | 1990 | 8 | |
| 13 | 1990 | 4 | |
| 14 | 1989 | 6 | |
| 15 | 1989 | 14 | |
| 16 | [A case of post-mastectomy lymphangiosarcoma]. | 1988 | 2 |
| 17 | Mitotic Delay and its Variation With the Age of the Cells, After X-ray and Fast-neutron Irradiations - a Time-lapse Cinephotomicrographic Study | 1987 | 2 |
| 18 | 1987 | 159 | |
| 19 | 1981 | 0 | |
| 20 | [The interest of beta2-microglobulin in the cancer (author's transl)]. | 1978 | 1 |
About M. Beauduin
M. Beauduin is a scholar working on Oncology, Cancer Research and Radiation, having authored 70 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (17 papers), Breast Cancer Treatment Studies (16 papers), Estrogen and related hormone effects (8 papers), HER2/EGFR in Cancer Research (7 papers), Nuclear Physics and Applications (6 papers), Radiation Therapy and Dosimetry (5 papers), Prostate Cancer Treatment and Research (5 papers) and Cancer therapeutics and mechanisms (4 papers). The work is most often cited by research in Oncology (662 citations), Radiation (133 citations) and Cancer Research (224 citations). M. Beauduin has collaborated with scholars based in Belgium, France and United States. Frequent co-authors include F. Majois, Yves Humblet, J Longueville, P. Weynants, A. Vindevoghel, André Wambersie, Martine Piccart, Michel Symann, Luc Delaunois and Charles K. Francis. Their work appears in journals such as European Journal of Cancer, Journal of Clinical Oncology, Radiotherapy and Oncology, Radiation Research and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.